Lung Cancer
From the Editor
ASCO 2015: from data and learning, to daily practice
News
Gefitinib approved for first-line EGFR-positive metastatic NSCLC
teaser
News
FDA panel says benefits of necitumumab for squamous NSCLC outweigh risks
From the Journals
Consolidation chemotherapy after concurrent chemoradiation failed to improve outcomes in NSCLC
Key clinical point: Docetaxel and cisplatin consolidation chemotherapy (CC) after concurrent chemoradiation failed to prolong progression-free...
David Henry's JCSO Podcast
David Henry's JCSO podcast, June 2015
Conference Coverage
AATS: Metformin linked to better progression-free survival in early-stage NSCLC
Metformin use was linked to a 25% improvement in progression-free survival
News
Invasive approaches ‘overused’ for evaluating pulmonary nodules
Key clinical point: One in four pulmonary nodules 8-20 mm in size are malignant, and invasive tests are being overused in low-risk patients in...
Original Report
Impact of nurse navigation on timeliness of diagnostic medical services in patients with newly diagnosed lung cancer
News
Cigarettes account for slightly under half of smoking-related cancer deaths
Conference Coverage
ASCO: Precision medicine initiatives take wing
News
Nivolumab transforms practice for advanced, refractory nonsquamous NSCLC
Key clinical point: Nivolumab provided superior overall survival vs. docetaxel and should be considered the new standard of care for previously...